A blood group transplant refers to organ or stem cell transplants between individuals with different blood types. Matching blood types helps prevent immune rejection and increases the likelihood of success. This article explores compatibility, challenges, and solutions in ABO-incompatible kidney and stem cell transplants.
Blood group matching is essential for transplants. The four major types—A, B, AB, and O—are defined by antigens on red blood cells:
Rh factor (+ or -) adds an additional layer in determining compatibility.
These require both blood and tissue (HLA) matching. Interestingly, a recipient’s blood type may change post-transplant to match the donor’s. Mismatches can be tolerated in select cases, especially in pediatric patients.
Historically considered risky, ABO-incompatible transplants are now possible with:
Removes antibodies from the recipient’s blood to reduce the chance of rejection.
Medications suppress the immune response, allowing successful transplants even with blood group mismatches.
Following successful engraftment, a recipient’s blood type may change to the donor’s as new cells are generated from transplanted stem cells.
Blood group compatibility plays a central role in transplant success. While ABO-incompatible transplants are becoming more feasible, matched donors still offer the best outcomes.
Schedule a consultation with Dr. Mukherjee to explore compatibility testing and personalized transplant planning.
Prof (Dr) D Mukherjee is an alumnus of the prestigious Armed Forces Medical College, Pune where he did his MBBS & MD (Medicine). Subsequently he went on to do his DM (Nephrology) from PGIMER Chandigarh, which is the foremost training institution for nephrology in India.